Mangalam Drugs & Organics (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Mangalam Drugs & Organics Limited |
|||
|
Price: ₹114.61 | ||
| 52 Week Low: ₹90.80 52 Week High: ₹144.99 |
|||
| Market Capital: 164.48 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Mangalam Drugs & Organics Share Price Target For 2024
- 1.1.1: Mangalam Drugs & Organics Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Mangalam Drugs & Organics Share Price Target For 2025
- 1.2.1: Mangalam Drugs & Organics Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Mangalam Drugs & Organics Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Mangalam Drugs & Organics Brief Company Overview
- 4: Mangalam Drugs & Organics Financial Performance
- 4.0.1: Is Mangalam Drugs & Organics A Good Buy For Long Term?
To predict the Mangalam Drugs & Organics's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Mangalam Drugs & Organics Share Price Target For 2024
The line chart displays the monthly closing prices of Mangalam Drugs & Organics with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Mangalam Drugs & Organics shares in 2024, see the table below.
Mangalam Drugs & Organics Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 119.69 (+4.43%) | Price Action: Sep 2020 Low |
| 2024 Target 2 | 118.4 (+3.3%) | Price Action: Mar 2022 High |
| 2024 Target 1 | 117.21 (+2.25%) | Price Action: 19 Dec 2024 High |
| Current Price | 114.61 | Mangalam Drugs & Organics's share price as of 23 Dec 2024 |
| Stop Loss 1 | 113.71 (-0.79%) | Price Action: 25 Oct 2024 High |
| Stop Loss 2 | 112.53 (-1.82%) | Price Action: 07 Nov 2024 High |
| Stop Loss 3 | 111.32 (-2.88%) | Technical Indicator: MA200 |
Short-Term Technical Outlook
Current Technical Position: Mangalam Drugs & Organics is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹114.74 serves as the nearest technical reference point.
Historical Returns: 3-month: -10.13% | 6-month: +10.83% | 1-year: +16.92%
Mangalam Drugs & Organics Share Price Target For 2025
The line chart displays the monthly closing prices of Mangalam Drugs & Organics with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Mangalam Drugs & Organics shares in 2025, see the table below.
Mangalam Drugs & Organics Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 154.15 (+34.49%) | Price Action: Chart |
| 2025 Target 2 | 151.28 (+31.99%) | Price Action: Chart |
| 2025 Target 1 | 149.78 (+30.68%) | Fibonacci Extension Level 64.90% |
| Current Price | 114.61 | Mangalam Drugs & Organics's share price as of 23 Dec 2024 |
| Stop Loss 1 | 106.2 (-7.34%) | Price Action: 28 Nov 2024 Low |
| Stop Loss 2 | 104.88 (-8.49%) | Price Action: 25 Oct 2024 Low |
| Stop Loss 3 | 103.66 (-9.56%) | Price Action: 21 Nov 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Mangalam Drugs & Organics is currently trading at 43.9% of its 52-week range (₹90.8 - ₹144.99).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +16.92% | 3-year: -11.79% | 5-year: +317.31%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Mangalam Drugs & Organics Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹114.61 | ||
| 2024 | ₹105.30 | -8.12% | ₹106.88 |
| 2025 | ₹122.63 | +16.45% | ₹124.47 |
| 2026 | ₹140.74 | +14.76% | ₹142.85 |
| 2027 | ₹126.99 | -9.76% | ₹140.07 |
| 2028 | ₹142.68 | +12.35% | ₹149.88 |
| 2029 | ₹135.80 | -4.82% | ₹159.01 |
| 2030 | ₹156.21 | +15.02% | ₹168.15 |
| 2031 | ₹177.28 | +13.48% | ₹179.94 |
| 2032 | ₹158.34 | -10.68% | ₹176.28 |
| 2033 | ₹176.24 | +11.3% | ₹186.42 |
| 2034 | ₹166.31 | -5.63% | ₹195.55 |
| 2035 | ₹189.80 | +14.12% | ₹204.69 |
| 2036 | ₹213.82 | +12.65% | ₹217.03 |
| 2037 | ₹189.68 | -11.28% | ₹212.49 |
| 2038 | ₹209.80 | +10.6% | ₹222.96 |
| 2039 | ₹189.60 | -9.62% | ₹232.09 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Mangalam Drugs & Organics Brief Company Overview
Mangalam Drugs & Organics Limited: A Pharmaceutical Powerhouse Mangalam Drugs & Organics Limited has been a leading manufacturer of active pharmaceutical ingredients (APIs) since its inception in 1972. Headquartered in Mumbai, India, the company has a strong global...
presence. Key Products and Services: APIs: Acyclovir, Amodiaquine, Artemether, and more Intermediates: 2-Dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol, 4,6-Dichloro-5-methoxy pyrimidine Specialty Chemicals: Menthol, 2,3-Dihydrophthalazine-1, 4-dione Products Under Development: Tafenoquine Succinate, Bictegravir Na, Favipiravir, and others Reputation and Commitment: Mangalam Drugs has earned a strong reputation for its quality products and commitment to innovation. The company's diverse product range caters to the needs of various pharmaceutical industries. Its ongoing research and development efforts ensure a steady stream of new products.Mangalam Drugs & Organics Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 164.48 Crore | Market valuation of Mangalam Drugs & Organics's shares. |
| Revenue (TTM) | 356.84 Crore | Total revenue generated by Mangalam Drugs & Organics over the past twelve months. |
| Net Income (TTM) | +3.14 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +5.63% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +0.88% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-12.1% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
78.79 | Company's total debt divided by total shareholder equity. |
| Total Debt | 106.99 Crore | Sum of Mangalam Drugs & Organics's current & long-term financial obligations. |
| Total Cash | 91.14 Lakh | Total amount of liquid funds available to Mangalam Drugs & Organics. |
| Beta | 0.74 | Beta is less than 1 indicating that the Mangalam Drugs & Organics's price is less volatile than the market. |
Is Mangalam Drugs & Organics A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
